» Articles » PMID: 21484848

On the C-statistics for Evaluating Overall Adequacy of Risk Prediction Procedures with Censored Survival Data

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2011 Apr 13
PMID 21484848
Citations 604
Authors
Affiliations
Soon will be listed here.
Abstract

For modern evidence-based medicine, a well thought-out risk scoring system for predicting the occurrence of a clinical event plays an important role in selecting prevention and treatment strategies. Such an index system is often established based on the subject's 'baseline' genetic or clinical markers via a working parametric or semi-parametric model. To evaluate the adequacy of such a system, C-statistics are routinely used in the medical literature to quantify the capacity of the estimated risk score in discriminating among subjects with different event times. The C-statistic provides a global assessment of a fitted survival model for the continuous event time rather than focussing on the prediction of bit-year survival for a fixed time. When the event time is possibly censored, however, the population parameters corresponding to the commonly used C-statistics may depend on the study-specific censoring distribution. In this article, we present a simple C-statistic without this shortcoming. The new procedure consistently estimates a conventional concordance measure which is free of censoring. We provide a large sample approximation to the distribution of this estimator for making inferences about the concordance measure. Results from numerical studies suggest that the new procedure performs well in finite sample.

Citing Articles

Change in diffusion weighted imaging after induction chemotherapy outperforms RECIST guideline for long-term outcome prediction in advanced nasopharyngeal carcinoma.

Ai Q, Leung H, Mo F, Mao K, Wong L, Liang Y Cancer Imaging. 2025; 25(1):32.

PMID: 40075537 PMC: 11905565. DOI: 10.1186/s40644-025-00854-4.


Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab.

Gairing S, Mildenberger P, Gile J, Artusa F, Scheiner B, Leyh C JHEP Rep. 2025; 7(3):101295.

PMID: 40059970 PMC: 11889551. DOI: 10.1016/j.jhepr.2024.101295.


Identifying high-risk candidates for prolonging progression-free survival in primary gastric carcinoma subject to "double invasion": an analytical approach utilizing lasso-cox regression.

Wang L, Chang Y, Ma J, Qu W, Li Y BMC Cancer. 2025; 25(1):381.

PMID: 40022037 PMC: 11871700. DOI: 10.1186/s12885-025-13810-z.


Poor air quality raises mortality in honey bees, a concern for all pollinators.

Coallier N, Perez L, Fraser Franco M, Cuellar Y, Vadnais J Commun Earth Environ. 2025; 6(1):126.

PMID: 39990959 PMC: 11845317. DOI: 10.1038/s43247-025-02082-x.


Gene-environment interaction analysis under the Cox model.

Fang K, Li J, Xu Y, Ma S, Zhang Q Ann Inst Stat Math. 2025; 75(6):931-948.

PMID: 39990259 PMC: 11843211. DOI: 10.1007/s10463-023-00871-9.


References
1.
Anderson K, Odell P, Wilson P, Kannel W . Cardiovascular disease risk profiles. Am Heart J. 1991; 121(1 Pt 2):293-8. DOI: 10.1016/0002-8703(91)90861-b. View

2.
DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

3.
Pencina M, DAgostino R . Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004; 23(13):2109-23. DOI: 10.1002/sim.1802. View

4.
Chang H, Nuyten D, Sneddon J, Hastie T, Tibshirani R, Sorlie T . Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A. 2005; 102(10):3738-43. PMC: 548329. DOI: 10.1073/pnas.0409462102. View

5.
Korn E, Simon R . Measures of explained variation for survival data. Stat Med. 1990; 9(5):487-503. DOI: 10.1002/sim.4780090503. View